Cantor Fitzgerald restated an overweight rating for Anteris Technologies Global Corp. on October 8, 2026.
2 reports, 2 independent
Updated Oct 14
Gone quiet
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Cantor Fitzgerald restated an overweight rating for Anteris Technologies Global Corp. on October 8, 2026.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.A major shareholder bought stock in Anteris Technologies Global Corp. alongside a rating restatement.1 source
Cantor Fitzgerald restated an overweight rating for Anteris Technologies Global Corp.1 source
Keep exploring
The entities involved
-
Cantor Fitzgerald
American financial services company
Related events
- Cantor Fitzgerald restated an overweight rating and Royal Bank of Canada reduced its price objective for United Therapeutics.
- Cantor Fitzgerald reiterated its 'overweight' rating on Oracle stock on June 11, 2026.
- Cantor Fitzgerald and Royal Bank of Canada updated their ratings and positions regarding Rezolve Ai.
- Cantor Fitzgerald maintained a Buy rating on Meta.
- Briefing.com reported a rating change issued by Cantor Fitzgerald.